O
Obesity Research Institute
A $4.6 million settlement resolves claims that Lipozene weight loss pills were deceptively marketed.
ClosedUnited States-wideClaim status: Claim window closedPayout: Up to $60No longer claimable
About this settlement
Claims relate to deceptive advertising and marketing of Lipozene weight loss pills.
This settlement resolves allegations that the Obesity Research Institute misled consumers about the effectiveness of Lipozene weight loss pills. Eligible claimants could receive up to $60 from the $4.6 million fund.
Who qualifies
- Consumers who purchased Lipozene weight loss pills.
- Those who were allegedly misled by the product's marketing.
Up to $60
Claim status: Claim window closed